The only endometrial sampler to combine suction, disruption, and absorption — supporting earlier, more accurate cancer detection, even before symptoms appear.*
*The Utepreva Endometrial Sampler (UP01) is used to obtain endometrial cytological and histological samples.



The standard biopsy gets it wrong in 1 in 3 procedures.1 Utepreva combines three mechanisms to cover more of the uterine surface — for a larger, higher quality sample.
Sensitivity for
endometrial cancer²
From a single, in-office procedure.
More tissue
collected³
Than a leading sampler.
Independently tested. Statistically significant.
Supported analyses
in a single sample
One sample: three collection methods

Utepreva's design combines three complementary mechanisms of action — collecting more from a single endometrial sample than any single method alone.
Suction
Draws tissue directly into the collection chamber for immediate capture
Absorption
Retains cellular material across the full brush length — not just the tip
Disruption
Loosens endometrial tissue to maximize what’s collected.
Absorption
Retains cellular material across the full brush length — not just the tip
Disruption
Loosens endometrial tissue to maximize what’s collected.
Suction
Draws tissue directly into the collection chamber for immediate capture

After decades in the OR, Dr. Jeanetta Stega had seen thousands of times how an inadequate sample could cost a patient.
So she built the solution.



Uterine cancer is one of the only cancers in America where mortality is still climbing. We believe that's not acceptable. Utepreva is built with clinical precision — and a fierce commitment to the women it serves.

U.S. cases estimated in 20264
Deaths expected this year5
Mortality rate for Black women vs. white6
Annual increase in death rate since the mid-2000s7


And improve endometrial cancer diagnoses, one sampler at a time.